Nimbus Therapeutics
Latest round
- Series B
Last raised
- Mar 2015
Total raised
- $69M
Investors
- 5
About Nimbus Therapeutics
Founded in 2009 and based in Massachusetts, US, Nimbus Discovery, Inc. operates as a biotechnology company that develops pharmaceutical solutions by utilizing computational chemistry. Bruce Booth and Ramy Farid co-founded the company, and Jeb Keiper is the current CEO. In July 2021, Nimbus Discovery, Inc., RA Capital Management, Atlas Venture, Access Biotechnology, Commodore Capital, Logos Capital, and Surveyor Capital. The company offers a computational technology-driven paradigm intended to design challenging target medicines and transform drug development for novel diseases such as metabolic diseases, cancer, and immune-inflammatory disorders. The company also designs novel small molecule candidates, enabling physicians to use such medicine to treat various metabolic diseases. Nimbus Discovery, Inc. The company expects to initiate IND-enabling studies on two novel agents in 2022.
Who invested in Nimbus Therapeutics
5 investors across 3 rounds
See all investors in Nimbus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nimbus Therapeutics
Who invested in Nimbus Therapeutics?
Nimbus Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nimbus Therapeutics raised?
Nimbus Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nimbus Therapeutics last raise money?
Nimbus Therapeutics's most recent round on record is a Series B, in Mar 2015.
What does Nimbus Therapeutics do?
Founded in 2009 and based in Massachusetts, US, Nimbus Discovery, Inc.
Where is Nimbus Therapeutics headquartered?
Nimbus Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Nimbus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nimbus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nimbus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.